April 21 – 22, 2018
From the event website:
Summary: Psychedelics 101 & 102 is an upcoming 2-day training offered by psychologists Ingmar Gorman and Elizabeth Nielson, designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice. This training is hosted by The New School and the Psychedelic Education and Continuing Care Program in New York, New York, on April 21-22, 2018.
This 2-day training offered by psychologists Ingmar Gormanand Elizabeth Nielson is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics. Sign up for either or both days (recommended).
Psychedelics 101: Your patients are curious and so are you: What is all this about psychedelics being used for treatment of addiction and trauma? This session gives an overview of psychedelic drugs, their history, and current research with MDMA and Psilocybin-assisted therapy. This program includes overview of recent and current clinical trials, outcomes, legal status, and what it all means for the future of addiction and trauma treatment.
Objectives: Participants will be able to articulate the justifications for psychedelic clinical research, answer clients’ basic questions about the state of psychedelic clinical research, rescheduling efforts, and how psychedelic-assisted psychotherapy works.
Psychedelics 102: What is psychedelic harm reduction and integration and how can they occur in a clinical setting? This session focuses on translating research findings into clinical practice including working with patients who are considering using psychedelics, actually using psychedelics, or have used them. This program includes discussion of assessment and integration techniques, resources, and legal and ethical issues.
Objectives: Participants will be able to engage in basic psychedelic harm reduction (safety planning) with clients, define and differentiate psychedelic integration psychotherapy, and identify key “red flags” that indicate someone should seek specialized psychiatric care after a psychedelic experience.
For more information, visit the event website.